347 related articles for article (PubMed ID: 28435453)
1. SiRNA Delivery with PEGylated Graphene Oxide Nanosheets for Combined Photothermal and Genetherapy for Pancreatic Cancer.
Yin F; Hu K; Chen Y; Yu M; Wang D; Wang Q; Yong KT; Lu F; Liang Y; Li Z
Theranostics; 2017; 7(5):1133-1148. PubMed ID: 28435453
[TBL] [Abstract][Full Text] [Related]
2. Folic acid-functionalized graphene oxide nanosheets via plasma etching as a platform to combine NIR anticancer phototherapy and targeted drug delivery.
Mauro N; Scialabba C; Agnello S; Cavallaro G; Giammona G
Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110201. PubMed ID: 31761243
[TBL] [Abstract][Full Text] [Related]
3. A Light-Driven Therapy of Pancreatic Adenocarcinoma Using Gold Nanorods-Based Nanocarriers for Co-Delivery of Doxorubicin and siRNA.
Yin F; Yang C; Wang Q; Zeng S; Hu R; Lin G; Tian J; Hu S; Lan RF; Yoon HS; Lu F; Wang K; Yong KT
Theranostics; 2015; 5(8):818-33. PubMed ID: 26000055
[TBL] [Abstract][Full Text] [Related]
4. Combined silencing of K-ras and Akt2 oncogenes achieves synergistic effects in inhibiting pancreatic cancer cell growth in vitro and in vivo.
Shi XH; Liang ZY; Ren XY; Liu TH
Cancer Gene Ther; 2009 Mar; 16(3):227-36. PubMed ID: 18949011
[TBL] [Abstract][Full Text] [Related]
5. Receptor-targeted, drug-loaded, functionalized graphene oxides for chemotherapy and photothermal therapy.
Thapa RK; Choi JY; Poudel BK; Choi HG; Yong CS; Kim JO
Int J Nanomedicine; 2016; 11():2799-813. PubMed ID: 27358565
[TBL] [Abstract][Full Text] [Related]
6. Plasmid-Based Stat3 siRNA Delivered by Functional Graphene Oxide Suppresses Mouse Malignant Melanoma Cell Growth.
Yin D; Li Y; Guo B; Liu Z; Xu Y; Wang X; Du Y; Xu L; Meng Y; Zhao X; Zhang L
Oncol Res; 2016; 23(5):229-36. PubMed ID: 27098146
[TBL] [Abstract][Full Text] [Related]
7. Functional graphene oxide as a plasmid-based Stat3 siRNA carrier inhibits mouse malignant melanoma growth in vivo.
Yin D; Li Y; Lin H; Guo B; Du Y; Li X; Jia H; Zhao X; Tang J; Zhang L
Nanotechnology; 2013 Mar; 24(10):105102. PubMed ID: 23425941
[TBL] [Abstract][Full Text] [Related]
8. Glycyrrhetinic acid-modified graphene oxide mediated siRNA delivery for enhanced liver-cancer targeting therapy.
Qu Y; Sun F; He F; Yu C; Lv J; Zhang Q; Liang D; Yu C; Wang J; Zhang X; Xu A; Wu J
Eur J Pharm Sci; 2019 Nov; 139():105036. PubMed ID: 31446078
[TBL] [Abstract][Full Text] [Related]
9. "Gold nanoparticles composite-folic acid conjugated graphene oxide nanohybrids" for targeted chemo-thermal cancer ablation: In vitro screening and in vivo studies.
Chauhan G; Chopra V; Tyagi A; Rath G; Sharma RK; Goyal AK
Eur J Pharm Sci; 2017 Jan; 96():351-361. PubMed ID: 27721039
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin and anti-VEGF siRNA co-delivery via nano-graphene oxide for enhanced cancer therapy in vitro and in vivo.
Sun Q; Wang X; Cui C; Li J; Wang Y
Int J Nanomedicine; 2018; 13():3713-3728. PubMed ID: 29983564
[TBL] [Abstract][Full Text] [Related]
11. Graphene-based nanosheets for delivery of chemotherapeutics and biological drugs.
Shim G; Kim MG; Park JY; Oh YK
Adv Drug Deliv Rev; 2016 Oct; 105(Pt B):205-227. PubMed ID: 27085467
[TBL] [Abstract][Full Text] [Related]
12. Functionalized MoS
Yin F; Anderson T; Panwar N; Zhang K; Tjin SC; Ng BK; Yoon HS; Qu J; Yong KT
Nanotheranostics; 2018; 2(4):371-386. PubMed ID: 30324083
[TBL] [Abstract][Full Text] [Related]
13. Platinated graphene oxide: A nanoplatform for efficient gene-chemo combination cancer therapy.
Liu P; Wang S; Liu X; Ding J; Zhou W
Eur J Pharm Sci; 2018 Aug; 121():319-329. PubMed ID: 29906508
[TBL] [Abstract][Full Text] [Related]
14. Fabrication of Graphene and AuNP Core Polyaniline Shell Nanocomposites as Multifunctional Theranostic Platforms for SERS Real-time Monitoring and Chemo-photothermal Therapy.
Chen H; Liu Z; Li S; Su C; Qiu X; Zhong H; Guo Z
Theranostics; 2016; 6(8):1096-104. PubMed ID: 27279904
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA.
Zhang YA; Nemunaitis J; Samuel SK; Chen P; Shen Y; Tong AW
Cancer Res; 2006 Oct; 66(19):9736-43. PubMed ID: 17018633
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional Nanographene Oxide for Targeted Gene-Mediated Thermochemotherapy of Drug-resistant Tumour.
Zeng Y; Yang Z; Li H; Hao Y; Liu C; Zhu L; Liu J; Lu B; Li R
Sci Rep; 2017 Mar; 7():43506. PubMed ID: 28272412
[TBL] [Abstract][Full Text] [Related]
17. Dual-functionalized graphene oxide for enhanced siRNA delivery to breast cancer cells.
Imani R; Shao W; Taherkhani S; Emami SH; Prakash S; Faghihi S
Colloids Surf B Biointerfaces; 2016 Nov; 147():315-325. PubMed ID: 27543693
[TBL] [Abstract][Full Text] [Related]
18. Effective suppression of the Kirsten rat sarcoma viral oncogene in pancreatic tumor cells via targeted small interfering RNA delivery using nanoparticles.
Zeng L; Li J; Li J; Zhang Q; Qian C; Wu W; Lin Z; Liang J; Chen Y; Huang K
Pancreas; 2015 Mar; 44(2):250-9. PubMed ID: 25401377
[TBL] [Abstract][Full Text] [Related]
19. Functionalized Graphene@Gold Nanostar/Lipid for Pancreatic Cancer Gene and Photothermal Synergistic Therapy under Photoacoustic/Photothermal Imaging Dual-Modal Guidance.
Jia X; Xu W; Ye Z; Wang Y; Dong Q; Wang E; Li D; Wang J
Small; 2020 Oct; 16(39):e2003707. PubMed ID: 32851808
[TBL] [Abstract][Full Text] [Related]
20. Preparation and Characterization of Functionalized Graphene Oxide Carrier for siRNA Delivery.
Li J; Ge X; Cui C; Zhang Y; Wang Y; Wang X; Sun Q
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30336549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
